Volume 13, Issue 6, October 2019

Index

REVIEW ONCOLOGY

Low Grade Glioma: towards a personalised treatment

S. Dingenen, L. Renard, T.M. Lawson, N. Whenham


Introducing a Castrate Resistant Prostate Cancer (CRPC) Model Care Pathway in Belgian Hospitals - towards national standardisation?

T. Vermassen, T. Roumeguère, Y. Neybuch, L. Hoekx, I. Fele, B. Sautois, W. Everaerts, D. De Maeseneer, F. Lecouvet, N. Lumen, P. Ost, S. Rorive, S. Stroobants, P. Dirix, S. Rottey


PRACTICE GUIDELINES

State of the art in the treatment of soft tissue sarcomas

C. Gennigens, G. Jerusalem


PHARMACOTHERAPY

Adjuvant chemotherapy of colon cancer: 3 versus 6 months

C. Debeuckelaere, L. Triest, T. Vandamme, B. Van den Heuvel, K. Papadimitriou, M. Rasschaert, H. Prenen, M. Peeters


Appropriateness of treatment options in patients with metastatic castrationresistant prostate cancer with a focus on radium-223: outcomes of a Belgian multidisciplinary Consensus Meeting

P. Ost, D. Schrijvers, L. Duck, M. Gizzi, K. Goffin, S. Joniau, S. Rottey, T. Roumeguère, E. Seront, N. Withofs, B. Tombal


CONGRESS NEWS

Highlights of the 2019 annual meeting of the European Neuroendocrine Tumour Society (ENETS)

W. Lybaert, T. Vandamme, G. Boons, K. Vandenborne, L. De Backer, M. Peeters


REIMBURSEMENT NEWS

New oncology reimbursements in Belgium

P. Specenier


X